The new mRNA vaccine provides more protection than the standard flu shot.

Vaccines reduce the risk of children and teens dying from flu by 80%, the AAP said in its Monday statement. But for last flu ...

Although experts estimate COVID vaccines saved more than three million American lives, a survey found only 56% of Americans ...

The United States is finally getting a new type of flu shot. On August 5, the Food and Drug Administration (FDA) approved the mFlusiva vaccine for adults ages 50 and up. Made by biotechnology company ...

Compared with standard flu shots, Moderna’s mFlusiva generates stronger, longer-lasting immunity and is more effective at ...

The shot, made by Moderna, will be available for this year's upcoming flu season.

Previously, the COVID-19 immunizations made by Pfizer and Moderna were the only mRNA vaccines on the market.

The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu season.

The approval of the vaccine, called mFLUSIVA, which is manufactured by Moderna, follows a series of blows to mRNA research ...

The agency's former top vaccine regulator declined to review the Moderna shot, and it's now likely to face pushback from ...